ESCRS - 510(k) FDA clearance ;

510(k) FDA clearance

Topcon Medical Systems has received 510(k) clearance from the FDA for its DRI OCT Triton Series

Colin Kerr

Published: Friday, June 1, 2018

Topcon Medical Systems has received 510(k) clearance from the FDA for its DRI OCT Triton Series. “The DRI OCT Triton features exceptionally easy image capture and a 1 micron, 1050nm light source with a scanning speed of 100,000 A-scans/second,” said a company spokesman. In a press release announcing the FDA 510 k clearance, Topcon said that in addition to anterior segment scanning, the DRI OCT Triton can visualise deeper pathology, rapidly penetrating ocular tissues such as the choroid and even the sclera, without being obscured by media opacities or haemorrhage. “The DRI OCT Triton can visualise from vitreous through to sclera at the press of a single button with high sensitivity and speed. The instantaneous capture of a high-density data cube, comprised of 512 B-scans, reduces interpolation between slices and allows the most revealing imagery,” according to Topcon. www.topcon-medical.eu

Latest Articles

From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Best of ESCRS Winter Meeting 2024

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

;